Altium Capital Management LP Castle Biosciences Inc Transaction History

Altium Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $1.35 Million - $2.06 Million	60,000 New	60,000 $1.57 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $2.83 Million - $4.9 Million	-72,500 Closed	0 $0
Q3 2021 Nov 17, 2021	BUY	$60.13 - $77.6 $4.36 Million - $5.63 Million	72,500 New	72,500 $4.82 Million
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $4.15 Million - $5.35 Million	-69,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$50.07 - $76.78 $2.08 Million - $3.2 Million	41,635 Added 152.15%	69,000 $5.06 Million
Q1 2021 May 06, 2021	SELL	$58.92 - $97.33 $2.04 Million - $3.37 Million	-34,626 Reduced 55.86%	27,365 $1.87 Million
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $2.7 Million - $4.53 Million	61,991 New	61,991 $4.16 Million

171

25.5M

511K

130K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $750M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.